BEACON: An Adaptive Bayesian Early‐Phase Oncology Trial Design Integrating Dose Optimization and Proof‐of‐Concept Across Survival and Binary Endpoints

Yike Tang, Feng Tian, Xiaochen Zhu, Guotao Chu, Liangang Liu, Hsin‐Ju Hsieh, Shu‐Pang Huang
Pharmaceutical Statistics · Wiley · 2026-09-29 · DOI: 10.1002/pst.70127

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles